期刊文献+

肝硬化合并急性上消化道出血的预后评分系统对比 被引量:17

The Comparison of the Current Prognostic Models of Patients with Cirrhosis and Acute Variceal Bleeding
下载PDF
导出
摘要 目的对比现行的肝硬化合并急性上消化道出血的预后评分系统。方法回顾性分析2019年1~12月西安交通大学第一附属医院因肝硬化上消化道出血住院的患者资料,对比Child-Pugh评分、CAGIB评分、MELD评分及NLR评分系统的曲线下面积(area under curve,AUC)。结果共有328例肝硬化伴急性消化道出血的连续病例纳入分析。57例(17.4%)患者合并肝癌。在整体包含了328例患者的队列中,Child-Pugh评分、CAGIB评分、MELD评分及NLR评分的AUC值分别为0.836(95%CI:0.791~0.875)、0.827(95%CI:0.781~0.867)、0.764(95%CI:0.714~0.809)、0.687(95%CI:0.633~0.737)。其中,Child-Pugh与NLR之间差异有统计学意义(P=0.037)。在剔除肝癌的271例患者队列中,Child-Pugh评分、CAGIB评分、MELD评分及NLR评分的AUC值分别为0.840(95%CI:0.790~0.882)、0.728(95%CI:0.671~0.781)、0.742(95%CI:0.685~0.794)、0.726(95%CI:0.668~0.779)。结论相比于NLR评分系统,Child-Pugh评分、CAGIB评分、MELD评分对于肝硬化急性上消化道出血的院内死亡的预后评估具有更好的价值,Child-Pugh评分的预后价值最高。 Objective To validate the current prognostic models in patients with cirrhosis and acute variceal bleeding.Methods Patients with cirrhosis and acute variceal bleeding were retrospectively included from Jan 2019 to Dec 2019.Area under curves(AUCs)of cirrhosis acute gastrointestinal bleeding(CAGIB)score was compared with that of Child-Pugh,model for end-stage liver disease(MELD),and neutrophil-lymphocyte ratio(NLR)scores.Results In total,328 patients with liver cirrhosis and acute variceal bleeding were consecutively evaluated.57(17.4%)patients had hepatocellular carcinoma.In the whole cohort with HCC patients,the AUCs of Child-Pugh,CAGIB,MELD,NLR scores were 0.836(95%CI 0.791-0.875),0.827(95%CI 0.781-0.867),0.764(95%CI 0.714-0.809)and 0.687(95%CI 0.633-0.737),respectively.The differences were statistically significant between Child-Pugh and NLR scores(P=0.037).In the cohort without HCC,the AUCs of Child-Pugh,CAGIB,MELD,NLR scores were 0.840(95%CI 0.790-0.882),0.728(95%CI 0.671-0.781),0.742(95%CI 0.685-0.794)and 0.726(95%CI 0.668-0.779),respectively.Conclusion Our study suggested that Child-Pugh,CAGIB and MELD scores showed better predictive performance for prognosis of patients with cirrhosis and acute variceal bleeding than NLR scores.
作者 赵艳 赵倩 任牡丹 卢桂芳 卢新兰 和水祥 ZHAO Yan;ZHAO Qian;REN Mu-dan;LU Gui-fang;LU Xin-lan;HE Shui-xiang(Department of Gastroenterology,F irst Affiliated Hlospital of Xi'an Jiaotong University,Xi'an,710061,China)
出处 《现代消化及介入诊疗》 2021年第2期158-162,共5页 Modern Interventional Diagnosis and Treatment in Gastroenterology
基金 国家自然科学基金青年项目(81900489)。
关键词 肝硬化 急性上消化道出血 CHILD-PUGH评分 CAGIB评分 MELD评分 NLR评分 Cirrhosis Acute upper gastrointestinal bleeding Child-Pugh Model for end-stage liver disease(MELD) neutrophil-lymphocyte ratio(NLR) Cirrhosis acute gastrointestinal bleeding(CAGIB)
  • 相关文献

参考文献8

二级参考文献50

  • 1George V. Papatheodoridis,Evangelos Cholongitas,Eleni Dimitriadou,Giota Touloumi,Vassilios Sevastianos,Athanasios J. Archimandritis.MELD vs Child-Pugh and creatinine-modified Child-Pugh score for Dredicting survival in patients with decompensated cirrhosis[J].World Journal of Gastroenterology,2005,11(20):3099-3104. 被引量:31
  • 2Robert A Enns,Yves M Gagnon,Alan N Barkun,David Armstrong,Jamie C Gregor,Richard N Fedorak,RUGBE Investigators Group.Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting[J].World Journal of Gastroenterology,2006,12(48):7779-7785. 被引量:14
  • 3Yen YH, Changchien CS, Wang JH, et al. A modified ~M- based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepateeelluIar carcinoma patients [J]. Dig Liver Dis, 2009,41 (6) :431-441.
  • 4Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology, 2001, 33: 473-475.
  • 5Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001,33: 464-470.
  • 6夏德全 王吉耀 见:陈灏珠 主编.肝硬化[A].见:陈灏珠,主编.实用内科学.第10版[C].北京:人民卫生出版社,1997.16731689.
  • 7Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31: 864-871.
  • 8Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl, 2001, 7: 567-580.
  • 9Albert J. Czaja.Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis[J]. Current Pharmaceutical Design . 2011 (29)
  • 10Sara Lemoinne,Axelle Cadoret,Haquima El Mourabit,Dominique Thabut,Chantal Housset.Origins and functions of liver myofibroblasts[J].BBA - Molecular Basis of Disease.2013(7)

共引文献217

同被引文献199

引证文献17

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部